Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lackmann

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Growth Factors (Chur, Switzerland)|October 20, 1998
Biomolecular interaction analysis of IFN gamma-induced signaling events in whole-cell lysates: prevalence of latent STAT1 in high-molecular weight complexesM Lackmann, A G Harpur, A C Oates, et al.
The Journal of Biological Chemistry|June 27, 1997
Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptorM Lackmann, R J Mann, L Kravets, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 1996
Purification of a ligand for the EPH-like receptor HEK using a biosensor-based affinity detection approachM Lackmann, T Bucci, R J Mann, et al.
Leukemia|December 7, 2016
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaS Charmsaz, F Al-Ejeh, T M Yeadon, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Growth Factors (Chur, Switzerland)|October 20, 1998
Biomolecular interaction analysis of IFN gamma-induced signaling events in whole-cell lysates: prevalence of latent STAT1 in high-molecular weight complexesM Lackmann, A G Harpur, A C Oates, et al.
The Journal of Biological Chemistry|June 27, 1997
Ligand for EPH-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptorM Lackmann, R J Mann, L Kravets, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 1996
Purification of a ligand for the EPH-like receptor HEK using a biosensor-based affinity detection approachM Lackmann, T Bucci, R J Mann, et al.
Leukemia|December 7, 2016
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemiaS Charmsaz, F Al-Ejeh, T M Yeadon, et al.
Pageof 6